C12Y 304/23049
Omptin
Official title: Omptin (3.4.23.49)
C12Y304/23049 (Omptin) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 4
- Inventors
- 9
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered Microbes Comprising Tumor Neoantigen Vectors for Cancer Immunotherapy18 Jun 2026US 2026/0166133 A1The Trustees of Columbia University in the City of New York
- Salmonella engineered for nontoxic colonization of tumors2 Jan 2025US 2025/0000913 A1Regents of the University of Minnesota
- Cell-Free Expression System Having Novel Inorganic Polyphosphate-Based Energy Regeneration28 Jan 2021US 2021/0024912 A1NTxBio, LLC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.